Citations as recorded by:

1. Gradual thrombocytopenia induced by long-term trastuzumab exposure

J Clin Pharm Ther, 2016, 41(5) p. 563

DOI: 10.1111/jcpt.12416

Citations as recorded by: Cross Ref

2. HOXB7-S3 inhibits the proliferation and invasion of MCF-7 human breast cancer cells

12(4) p. 4901

DOI: 10.3892/mmr.2015.4009

Citations as recorded by: Cross Ref PMC Google

3. Severe Thrombocytopenia Induced by Second Exposure to Trastuzumab Can Be Alleviated by Prolonging the Interval Between Treatments

Clinical Breast Cancer, 2014, 14(2) p. e69

DOI: 10.1016/j.clbc.2013.11.004

Citations as recorded by: Cross Ref Google

4. Severe thrombocytopenia after trastuzumab retreatment: a case report

BMC Res Notes, 2013, 6(1) p. 400

DOI: 10.1186/1756-0500-6-400

Citations as recorded by: Cross Ref PMC Google

5. Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.

Toxicol Pathol, 2013, 41 p. 2

DOI: 1

Citations as recorded by: Google

6. Cyclophosphamide-rescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjögren's syndrome

Arch Med Sci, 2012, 8 p. 934

DOI: 10.5114/aoms.2012.30788

Citations as recorded by: Google

7. Letter to the editor: Cyclophosphamide-rescued plasmapheresis-unresponsive secondary thrombotic thrombocytopenic purpura caused by Sjögren's …

Year: 2012

Citations as recorded by: Google

8. [CITATION] [C] Severe thrombocytopenia: case report

Year: 2011

Citations as recorded by: Google